IFNα MODULATES THE RESPONSE TO BCG IMMUNOTHERAPY IN BLADDER CANCER PATIENTS WITH SPECIFIC CTLA4 SINGLE NUCLEOTIDE POLYMORPHISMS

被引：0
|
作者：
Mahendran, Ratha
Rahmat, Juwita Norasmara
Tham, Sin Mun
Lim, Yew Koon
Sng, Jen Hwei
Raman, Lata
Wai, Ma Zin Mar
Chan, Yiong Huak
Tsang, Woon Chau
Chiong, Edmund
Esuvaranathan, Kesavan
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.1999
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-05
引用
收藏
页码：E854 / E854
页数：1
相关论文
共 50 条
  • [1] CTLA4 SINGLE NUCLEOTIDE POLYMORPHISMS CORRELATE WITH RESPONSE TO BCG IMMUNOTHERAPY
    Mahendran, Ratha
    Tham, Sin Mun
    Rahmat, Juwita
    Sng, Jen Hwei
    Lim, Yew Koon
    Raman, Lata
    Wai, Ma Zin Mar
    Tsang, Woon Chau
    Chiong, Edmund
    Chan, Yiong Huak
    Esuvaranathan, Kesavan
    JOURNAL OF UROLOGY, 2014, 191 (04): : E364 - E364
  • [2] CTLA4 Single Nucleotide Polymorphisms correlate with response to BCG immunotherapy
    Lim, Y. K.
    Mahendran, R.
    Tham, S. M.
    Rahmat, J. N.
    Sng, J. H.
    Raman, L. N.
    Ma, Z. M. W.
    Tsang, W. C.
    Chiong, E.
    Chan, Y. H.
    Esuvaranathan, K.
    BJU INTERNATIONAL, 2014, 113 : 5 - 5
  • [3] CTLA4 SINGLE NUCLEOTIDE POLYMORPHISMS CORRELATE WITH RESPONSE TO BCG IMMUNOTHERAPY
    Mahendran, R.
    Tham, S. M.
    Rahmat, J. N.
    Lim, Y. K.
    Sng, J. H.
    Raman, L. N.
    Ma, Z. M. W.
    Tsang, W. C.
    Chiong, E.
    Chan, Y. H.
    Esuvaranathan, K.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E8 - E9
  • [4] Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease
    Schott, Eckart
    Witt, Heiko
    Pascu, Maria
    van Boemmel, Florian
    Weich, Viola
    Bergk, Alexandra
    Halangk, Juliane
    Mueller, Tobias
    Puhl, Gero
    Wiedenmann, Bertram
    Berg, Thomas
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (11) : 947 - 951
  • [5] Intravesical IFN-α and BCG immunotherapy for patients with recurrent bladder cancer after previous BCG therapy
    Rahmat, J.
    Raman, L.
    Chan, Y. H.
    Mahendran, R.
    Chiong, E.
    Esuvaranathan, K.
    BJU INTERNATIONAL, 2014, 113 : 10 - 11
  • [6] Pharmacogenetic analysis of CTLA4 gene polymorphisms and response to tremelimumab in patients with advanced melanoma
    Richmond, J.
    Gao, F.
    Wood, L.
    Bulanhagui, C. A.
    Penny, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] GMCSF AND IFNα GENE THERAPY IMPROVED RESPONSE TO BCG IMMUNOTHERAPY IN A MURINE MODEL OF BLADDER CANCER
    Tham, Sin Mun
    Abirami, R.
    Esuvaranathan, Kesavan
    Mahendran, Ratha
    JOURNAL OF UROLOGY, 2015, 193 (04): : E538 - E538
  • [8] CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients
    Goltz, Diane
    Gevensleben, Heidrun
    Vogt, Timo J.
    Dietrich, Joern
    Golletz, Carsten
    Bootz, Friedrich
    Kristiansen, Glen
    Landsberg, Jennifer
    Dietrich, Dimo
    JCI INSIGHT, 2018, 3 (13):
  • [9] Gmcsf and Ifnα gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer
    Tham, Sin Mun
    Mahendran, Ratha
    Chiong, Edmund
    Wu, Qing Hui
    Esuvaranathan, Kesavan
    FUTURE ONCOLOGY, 2020, 16 (17) : 1179 - 1188
  • [10] CTLA4 CT60 Single-Nucleotide Polymorphism Is Associated with Slovenian Inflammatory Bowel Disease Patients and Regulates Expression of CTLA4 Isoforms
    Repnik, Katja
    Potocnik, Uros
    DNA AND CELL BIOLOGY, 2010, 29 (10) : 603 - 610
12345